For medical professionals read reference
Drug recommendation
Acute coronary syndrome (ACS) merger , how to formulate a drug treatment plan?
1
Drug selection
Patients with acute myocardial infarction should use β-blockers and renin-vascular tension (RAS) Blink agent and long -term use as a second -level prevention after the myocardial infarction. When the coronary spasm is considered, a large dose of beta blockers should be avoided.
If bango and hypertension are difficult to control, it can be in β -blockers, RAS blockageBased on the stagnation and thozide diuretic agent, long -acting dihydrial pyrine.
The combined β -blocker and RAS blocker still have left ventricular incomplete functionsPatients with myocardial infarction with aldosterone antagonists.
2
The antihypertensive strategy
Unstable Patients still blocked β receptorsThe agent and calcium channel block (toasting) as a first -line selection, the blood pressure control is not ideal, and the RAS blocker and diuretic agent can be combined.
In the 24H of acute myocardial infarction, blood flow dynamics is stable and there is no contraindication.Patients with β-blockers and /vascular tension II receptor antagonists (ACEI/ARB). For patients with severe hypertension or persistent myocardial ischemia,You can consider intravenous drugs, lowering blood pressure to about 160/100mmHg within 2-6H, and 24-48H.
Patients with acute myocardial infarction stable period, preferred β -blocker or ACEI/ARB, if the blood pressure cannot be controlled, it can be used as a dihydrine pyridine calcium channel block (amly toasting) and (or) azorine diuretic.
Extension Question:
= "3508khtj">Hypertension+coronary heart disease+diabetes, how to set the treatment plan?
Hypertension+coronary heart disease, how to use the beta blocker?
For more dried drugs, click Quick Check
Reference Source:
[1] Cardiovascular disease in China Medical Care International Exchange Promotion Association.Chinese expert consensus [J]. Chinese Medical Journal, 2022, 102 (10): 12.
